The National People's Congress held a meeting, and the latest news came from the "Drug Administration Law"!
-
Last Update: 2019-08-16
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
The third trial time of "Drug Administration Law" has been set! The announcement was made by Xinhua News Agency on August 15 in Beijing The 36th meeting of chairmen of the Standing Committee of the 13th National People's Congress was held in the Great Hall of the people in Beijing on the morning of August 15, presided over by Chairman Li Zhanshu It was decided that the 12th session of the Standing Committee of the 13th National People's Congress would be held in Beijing from August 22 to 26 The chairman's meeting recommended that the 12th session of the Standing Committee of the 13th National People's Congress consider the drug administration law of the people's Republic of China (Revised Draft) The revision process of Drug Administration Law of the people's Republic of China was promulgated on September 20, 1984: Drug Administration Law of the people's Republic of China (hereinafter referred to as "Drug Administration Law") and came into force on July 1, 1985 February 28, 2001: issued after the first revision of the drug administration law and implemented as of December 1, 2001 December 28, 2013: the first amendment to the drug administration law, which will come into force on December 28, 2013 April 23, 2015: the second amendment of the drug administration law is issued from the date of promulgation October 23, 2017: the amendment to the drug administration law (Draft for comments) was released October 26, 2018: the sixth session of the Standing Committee of the 13th National People's Congress closed at the Great Hall of the people in Beijing After voting, the amendment to the drug administration law was not adopted November 1, 2018: the website of the people's Congress of China announced the full text of the drug administration law (Revised Draft), and solicited opinions from all walks of life from November 1 to December 1 April 23, 2019: the 10th meeting of the Standing Committee of the 13th National People's Congress closed in the Great Hall of the people in Beijing After deliberation, the drug administration law (Revised Draft) was not adopted Since the drug administration law was first established in 1984, the first revision has spanned 17 years, and 18 years later, we have ushered in a significant second revision After the draft law is submitted to the Standing Committee of the National People's Congress for deliberation, it should be deliberated at three meetings of the Standing Committee, namely the three trial system In the first instance, we heard the proposer's explanation on the legal case, and then we conducted preliminary deliberation; in the second instance, we entered into an in-depth meeting around the key points, difficulties and relatively large differences in the draft law; in the third instance, we heard the report on the deliberation results of the Legal Committee, and then we continued our deliberation Generally speaking, a bill that has been put on the agenda of a meeting of the Standing Committee can be put to a vote after two deliberations of the Standing Committee when all parties agree; for a single or partial revision of an adjustment, if all parties agree, it can also be put to a vote after the first instance From "amendment" to "revision" and from the first, second and third trials, the drug administration law reflects that the central leadership attaches great importance to the people's drug use, the community's keen attention to drug management and the professional, livelihood and political attributes of drugs as special commodities It is expected that the revised Drug Administration Law will guide the sound development of the industry in the new pattern Statement: this opinion only represents the author, not the position of yaozhi.com, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.